INM — InMed Pharma Inc.
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 20 SEC-registered investment managers reported holding INM (InMed Pharma Inc.) in their latest 13F filings, with a combined reported value of $5.18M across 2.70M shares. That is -70.0% by share count (-203.95K shares) versus the previous quarter, while reported value moved -28.0%. Ownership is concentrated: the five largest holders account for 84.2% of reported value and the top ten for 95.8%.
Compared with the prior quarter, 14 opened new positions, 3 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of InMed Pharma Inc. (INM) include Caligan Partners LP, OAKTREE CAPITAL MANAGEMENT LP, EVENTIDE ASSET MANAGEMENT, LLC, ranked by reported 13F value among the 51 institutional holders on this page.
INM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 7 | 5.26M | $6.76M | +4.2% |
| Q2 2026 | 20 | 2.70M | $5.18M | -70.0% |
| Q1 2026 | 8 | 319.30K | $206.03K | +13.0% |
| Q4 2025 | 6 | 227.04K | $240.67K | -8.3% |
| Q3 2025 | 6 | 267.72K | $586.69K | +0.3% |
| Q2 2025 | 5 | 8.47K | $28.50K | +25.8% |
| Q1 2025 | 3 | 6.41K | $13.26K | -41.3% |
| Q4 2024 | 4 | 48.87K | $226.65K | -94.8% |
Over the 8 quarters shown, institutional share counts increased 10654% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (-94.8%).
Top Institutional Holders (Q3 2026) — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.35M | $5.53M | 0.08% | New | |
| 824.87K | $1.12M | 0.13% | Add | |
| 52.95K | $72.01K | 0.00% | Add | |
| 14.90K | $20.26K | 0.00% | Hold | |
| 5.00K | $6.80K | 0.00% | Hold | |
| 3.19K | $4.34K | 0.00% | New | |
| 300 | $408 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 800.00K | $1.24M | 0.07% | New | |
| 798.38K | $1.24M | 0.11% | New | |
| 6 | $1.00M | 0.00% | New | |
| 325.00K | $503.75K | 0.20% | New | |
| 245.03K | $379.79K | 0.06% | New | |
| 125.80K | $194.99K | 0.03% | New | |
| 100.00K | $155.00K | 0.00% | New | |
| 74.24K | $115.08K | 0.00% | New | |
| 44.97K | $69.70K | 0.51% | Reduce | |
| 43.08K | $66.77K | 0.00% | New | |
| 32.69K | $50.66K | 0.00% | New | |
| 26.08K | $40.43K | 0.00% | Reduce | |
| 25.00K | $38.75K | 0.00% | New | |
| 15.46K | $23.96K | 0.02% | New | |
| 14.90K | $23.09K | 0.00% | New | |
| 10.95K | $16.96K | 0.00% | Reduce | |
| 10.76K | $16.68K | 0.00% | New | |
| 5.00K | $7.75K | 0.00% | Hold | |
| 300 | $465 | 0.00% | Hold | |
| 2 | $4 | 0.00% | Hold |
Q1 2026 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 220.26K | $142.05K | 1.66% | Add | |
| 46.97K | $30.29K | 0.00% | New | |
| 19.98K | $13.00K | 0.00% | New | |
| 18.72K | $12.07K | 0.00% | New | |
| 8.07K | $5.20K | 0.00% | Add | |
| 5.00K | $3.23K | 0.00% | New | |
| 300 | $193 | 0.00% | Hold | |
| 2 | $2 | 0.00% | Hold |
Q4 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 201.63K | $213.73K | 1.56% | Reduce | |
| 12.75K | $13.52K | 0.00% | New | |
| 11.98K | $12.70K | 0.00% | New | |
| 377 | $400 | 0.00% | New | |
| 300 | $318 | 0.00% | Hold | |
| 2 | $2 | 0.00% | Hold |
Q3 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 220.00K | $481.80K | 1.52% | New | |
| 20.37K | $45.00K | 0.00% | New | |
| 16.80K | $36.79K | 0.00% | New | |
| 10.25K | $22.45K | 0.01% | New | |
| 300 | $657 | 0.00% | Hold | |
| 2 | $4 | 0.00% | Add |
Q2 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 7.76K | $25.23K | 0.00% | Add | |
| 400 | $1.30K | 0.00% | New | |
| 6 | $1.00K | 0.00% | New | |
| 300 | $975 | 0.00% | Hold | |
| 1 | $3 | 0.00% | Hold |
New Positions (Q2 2026)
- ADAR1 Capital Management, LLC 800.00K sh · $1.24M
- Vivo Capital, LLC 798.38K sh · $1.24M
- Banque Cantonale Vaudoise 6 sh · $1.00M
- Squadron Capital Management LLC 325.00K sh · $503.75K
- Ikarian Capital, LLC 245.03K sh · $379.79K
- Ursa Fund Management, LLC 125.80K sh · $194.99K
- MONTANOVA CAPITAL, LLC 100.00K sh · $155.00K
- BOOTHBAY FUND MANAGEMENT, LLC 74.24K sh · $115.08K
- JANE STREET GROUP, LLC 43.08K sh · $66.77K
- Venrock Adviser, LLC 32.69K sh · $50.66K
- SEVEN GRAND MANAGERS, LLC 25.00K sh · $38.75K
- Scientech Research LLC 15.46K sh · $23.96K
Fully Exited (vs previous quarter)
- Virtu Financial LLC sold 19.98K sh · $13.00K
- UBS Group AG sold 8.07K sh · $5.20K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 4.35M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 824.87K | 798.38K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 52.95K | 43.08K | — | 11.98K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Crestwood Advisors Group, LLC | 14.90K | 14.90K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Private Wealth Management Group, LLC | 5.00K | 5.00K | 5.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 3.19K | — | 8.07K | 377 | — | 7.76K | 6.11K | 10.41K | 212.04K | — | 41 | — | 69 | — | 2.62K | 831 | 5.80K | — | — | — |
| SBI Securities Co., Ltd. | 300 | 300 | 300 | 300 | 300 | 300 | 300 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SABBY MANAGEMENT, LLC | — | 44.97K | 220.26K | 201.63K | 220.00K | — | — | — | — | 307.24K | 361.73K | 511.93K | — | — | — | — | — | — | — | — |
| Caligan Partners LP | — | — | — | — | — | — | — | — | — | — | — | — | 1.20M | — | — | — | — | — | — | — |
| OAKTREE CAPITAL MANAGEMENT LP | — | — | — | — | — | — | — | — | — | — | — | — | 7.29M | — | — | — | — | — | — | — |
| Anson Funds Management LP | — | — | — | — | — | — | — | — | — | — | — | — | 4.00M | — | — | — | — | — | — | — |
| Russell Investments Group, Ltd. | — | — | — | — | — | — | — | — | — | — | — | — | 1.71M | — | — | — | — | — | — | — |
| ADAR1 Capital Management, LLC | — | 800.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Banque Cantonale Vaudoise | — | 6 | — | — | — | 6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Squadron Capital Management LLC | — | 325.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Ikarian Capital, LLC | — | 245.03K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Ursa Fund Management, LLC | — | 125.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AdvisorShares Investments LLC | — | — | — | — | — | — | — | 38.46K | 733.30K | — | — | — | — | — | — | — | — | — | — | — |
| MONTANOVA CAPITAL, LLC | — | 100.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BOOTHBAY FUND MANAGEMENT, LLC | — | 74.24K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold INM?
As of 2026-Q2, 20 institutional funds reported holding INM (InMed Pharma Inc.) in SEC 13F filings, with a combined reported value of $5.18M.
How many shares of INM do institutions own?
13F filers reported 2.70M shares of INM, worth $5.18M in aggregate at the end of 2026-Q2.
Is institutional ownership of INM rising or falling?
Share counts moved -70.0% versus the prior quarter — distribution.
Who are the top institutional holders of INM?
The largest 13F holders are Caligan Partners LP, OAKTREE CAPITAL MANAGEMENT LP, EVENTIDE ASSET MANAGEMENT, LLC, Anson Funds Management LP, Russell Investments Group, Ltd.; the top 25 are ranked at the top of this page.
Who are the major shareholders of InMed Pharma Inc.?
The major shareholders of InMed Pharma Inc. (INM) by reported 13F value are Caligan Partners LP, OAKTREE CAPITAL MANAGEMENT LP, EVENTIDE ASSET MANAGEMENT, LLC, Anson Funds Management LP, Russell Investments Group, Ltd., among 51 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.